Is Invesco RAFI Strategic US ETF (IUS) a Buy, Sell, or Hold?
NASDAQ : IUS
Invesco RAFI Strategic US ETF
$69.56 USD
-$0.14 (-0.2%)
- Volume
- 0
- Average Volume
- 59.6K
- Market Capitalization
- $893.5M
- P/E Ratio
- Dividend Yield
- %
- Price Target
- Year High
- $69.97
- Year Low
- $52.80
- Day High
- —
- Day Low
- —
- Payout Ratio
- Current Ratio
Company Overview
NASDAQ
Asset Management
Financial Services
IUS
N/A
US
USD
1-800-983-0903
46138J742
0001657201
Liquidity Metrics
Sales & Valuation
-$
Profitability
-$
%
%
%
%
P/E Metrics
Analyst Price Target & Rating
0/5
0 Analysts
%
Financial Health Scores
No financial score data available.
Key Metrics (TTM)
No key metrics data available.
Company Executives
No executive data available.
Poll Results
No votes yet today — be the first to share your view!
About Invesco RAFI Strategic US ETF (NASDAQ:IUS) Stock
The Invesco RAFI Strategic US ETF (the Fund) is designed to mirror the investment outcomes of the Invesco Strategic US Index (the Index). Typically, the Fund allocates at least 80% of its total assets to the securities that constitute this Index. The Index itself is constructed to measure the performance of prominent, high-quality American corporations. Securities are initially assigned a "Business-Size" score, which is an equally-weighted average of their sales, operating cash flow, total return of capital, and book value, calculated over the preceding five years or since the security's inception. For real estate-specific securities, this calculation adapts: funds from operations replace operating cash flow, and total assets substitute for book value. Next, a "Quality" score is determined ... for each security. This score is also an equally-weighted average, factoring in the company's efficiency (its sales-to-assets ratio from the prior year) and its growth (the percentage change in the sales-to-assets ratio over the last five years or the security's lifespan). For inclusion in the Index, eligible securities are first ranked in descending order by their Business-Size score. Only those falling within the top 90% by Business-Size are considered; from this subset, only the 80% possessing the highest Quality scores are ultimately selected. Once chosen, Index components are weighted based on their float-adjusted Business-Size scores. Both the Fund and the Index undergo annual rebalancing and reconstitution. As of August 31, 2022, Morningstar Inc. awarded the Fund an impressive overall 5-star rating, placing it among 1,154 comparable funds. It also achieved a 5-star rating for its 3-year performance (out of 1,154 funds), though ratings for the 5- and 10-year periods were not available. Morningstar's ratings are calculated using a risk-adjusted return metric that emphasizes consistent performance and accounts for downward fluctuations. For comparative purposes, open-end mutual funds and exchange-traded funds are grouped together. A fund must have at least a three-year track record to receive a rating. The overall rating is a weighted average of the 3-, 5-, and 10-year ratings, where applicable, and reflects fees and expenses but excludes sales charges. ©2022 Morningstar Inc. retains all proprietary rights to this information; it must not be copied or distributed, and its accuracy, completeness, or timeliness are not guaranteed. Morningstar and its content providers disclaim responsibility for any damages or losses stemming from the use of this information. Investors should note that past performance is not indicative of future results. Within a category, the top 10% of funds receive five stars, the next 22.5% four stars, and so on. Ratings are subject to monthly changes. It is also important to understand that if fees had not been waived or expenses reimbursed, the Morningstar rating might have been lower, and ratings can differ for other share classes due to varying performance characteristics.
Organon Opens REMS Program for MIUDELLA® Ahead of Anticipated Commercial Availability
2026-08-11 08:00:00
Organon (NYSE: OGN), a global healthcare company with a mission to deliver impactful medicines and solutions for a healthier every day, today announced the MIUD
Frequently Asked Questions
-
What is the current Invesco RAFI Strategic US ETF (IUS) stock price?
-
Invesco RAFI Strategic US ETF(NASDAQ:IUS) stock price is $69.56 in the last trading session. During the trading session, IUS stock reached the peak price of $69.97 while $52.8 was the lowest point it dropped to. The percentage change in IUS stock occurred in the recent session was --0.2% while the dollar amount for the price change in IUS stock was -$0.14.
-
IUS's industry and sector of operation?
-
The NASDAQ listed IUS is part of Asset Management industry that operates in the broader Financial Services sector.
-
Who are the executives of IUS?
-
|
|
|
|
| -
How many employees does IUS have?
-
Number of IUS employees currently stands at None. IUS operates from 3500 Lacey Road, Downers Grove, IL 60515, US.
-
Link for IUS official website?
-
Official Website of IUS is: https://www.invesco.com/us/en/financial-products/etfs/invesco-rafi-strategic-us-etf.html
-
How do I contact IUS?
-
IUS could be contacted at phone #1-800-983-0903 and can also be accessed through its website. IUS operates from 3500 Lacey Road, Downers Grove, IL 60515, US.
-
How many shares of IUS are traded daily?
-
The average number of IUS shares traded daily for last 3 months was 59.6K.
-
What is the market cap of IUS currently?
-
The market value of IUS currently stands at $893.5M with its latest stock price at $69.56